Image 1
Isradipine Capsule
Product Images NDC 16252-539
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Isradipine (NDC 16252-539). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Teva Pharmaceuticals Usa, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Image 2
Image 3
Image 4
This is a description for Isradipine Capsules, USP. The capsules are manufactured by PHRS in Forshan and by Actavis Pharma in Parsippany, USA. The package insert should be consulted for information on dosage. It should be stored in a container that is resistant to light and tightly sealed at 20°-25°C (68°-77°F) and is sold in a quantity of 100 capsules. The NDC (National Drug Code) is 16252-539-01.*
Image 5
This is a pharmaceutical label with dosage information for Isradipine capsules. It includes recommended storage conditions and a unique identifier (NDC code) for the medication. The label also notes that it is "Rx only" which indicates that this medication requires a prescription.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
